Author:
de Almeida Geanderson Emílio,Mororó Káliton Pereira,de Farias Emanuel Airton Oliveira,Eiras Carla
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
INCT iCEIS
Fundação de Amparo à Pesquisa do Estado do Piauí
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Horwitz H, Andersen JT, Dalhoff KP (2019) Health consequences of androgenic anabolic steroid use. J Intern Med 285(3):333–340. https://doi.org/10.1111/joim.12850
2. Filho SLAP, Gomes PEAC, Forte GA, Lima LLL, Júnior GBS, Meneses GC, Daher EDF (2020) Kidney disease associated with androgenic–anabolic steroids and vitamin supplements abuse: be aware! Nefrología (English Edition) 40(1):26–31. https://doi.org/10.1016/j.nefroe.2019.06.005
3. Anawalt BD (2018) Detection of anabolic androgenic steroid use by elite athletes and by members of the general public. Mol Cell Endocrinol 464:21–27. https://doi.org/10.1016/j.mce.2017.09.027
4. Pope HG Jr, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A (2014) The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict 23(4):371–377. https://doi.org/10.1111/j.1521-0391.2013.12118.x
5. Bastos, F. I. P. M., Vasconcellos, M. T. L. D., De Boni, R. B., Reis, N. B. D., Coutinho, C. F. D. S. (2017). III Levantamento Nacional sobre o uso de drogas pela população brasileira. Rio de Janeiro:FIOCRUZ/ICICT. https://www.arca.fiocruz.br/bitstream/handle/icict/34614/III%20LNUD_ENGLISH.pdf?sequence=2&isAllowed=y